Genkyotex announced the appointment of Elias Papatheodorou to the position of Chief Business Officer. Mr. Papatheodorou brings to Genkyotex more than 20 years of experience with international private and public biotechnology companies, most recently at Covagen AG. As Chief Business Officer of Covagen AG, Mr. Papatheodorou was instrumental in securing the sale of Covagen to Janssen Pharmaceuticals, a Johnson & Johnson Company.